2seventy bio, Inc. (TSVT)

$13.58

-0.32 (-2.30%)
Rating:
Recommendation:
-
Symbol TSVT
Price $13.58
Beta 0.000
Volume Avg. 0.37M
Market Cap 514.323M
Shares () -
52 Week Range 9.91-64.0
1y Target Est -
DCF Unlevered TSVT DCF ->
DCF Levered TSVT LDCF ->
ROE -231.89% Strong Sell
ROA -27.21% Sell
Operating Margin -
Debt / Equity 107.77% Buy
P/E -
P/B 1.38 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Biotechnology
NASDAQ Global Select

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.